BioVie, Inc. (BIVI)
1.43
+0.05
(+3.62%)
USD |
NASDAQ |
Oct 30, 16:00
1.42
-0.01
(-0.70%)
After-Hours: 20:00
BioVie Market Cap : 10.79M for Oct. 30, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 30, 2026 | 10.79M |
| October 29, 2026 | 10.41M |
| October 28, 2026 | 11.01M |
| October 27, 2026 | 10.86M |
| October 26, 2026 | 10.03M |
| October 23, 2026 | 9.353M |
| October 22, 2026 | 9.654M |
| October 21, 2026 | 9.504M |
| October 20, 2026 | 9.353M |
| October 19, 2026 | 10.33M |
| October 16, 2026 | 9.051M |
| October 15, 2026 | 8.523M |
| October 14, 2026 | 8.749M |
| October 13, 2026 | 9.051M |
| October 12, 2026 | 9.956M |
| October 09, 2026 | 10.48M |
| October 08, 2026 | 9.654M |
| October 07, 2026 | 10.56M |
| October 06, 2026 | 10.86M |
| October 05, 2026 | 10.86M |
| October 02, 2026 | 11.01M |
| October 01, 2026 | 11.09M |
| September 30, 2026 | 11.46M |
| September 29, 2026 | 11.62M |
| September 28, 2026 | 11.62M |
| Date | Value |
|---|---|
| September 25, 2026 | 12.11M |
| September 24, 2026 | 12.14M |
| September 23, 2026 | 12.29M |
| September 22, 2026 | 12.29M |
| September 21, 2026 | 12.29M |
| September 18, 2026 | 12.14M |
| September 17, 2026 | 13.43M |
| September 16, 2026 | 12.97M |
| September 15, 2026 | 13.20M |
| September 14, 2026 | 15.46M |
| September 11, 2026 | 14.56M |
| September 10, 2026 | 14.41M |
| September 09, 2026 | 14.86M |
| September 08, 2026 | 15.61M |
| September 04, 2026 | 15.09M |
| September 03, 2026 | 15.31M |
| September 02, 2026 | 15.31M |
| September 01, 2026 | 16.90M |
| August 31, 2026 | 17.20M |
| August 28, 2026 | 16.29M |
| August 27, 2026 | 16.52M |
| August 26, 2026 | 15.91M |
| August 25, 2026 | 15.76M |
| August 24, 2026 | 16.14M |
| August 21, 2026 | 14.71M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 291.49M |
| Amgen, Inc. | 251.93B |
| Anika Therapeutics, Inc. | 280.37M |
| BioCryst Pharmaceuticals, Inc. | 2.162B |
| Imunon, Inc. | 4.246M |
Market Cap Related Metrics
| Price to Book Value | 1.050 |
| Price | 1.43 |
| Earnings Yield | -223.6% |